Advances in the Structural Basis of GluN2A-Selective Negative Allosteric Modulators

<i>N</i>-Methyl-d-aspartate receptors (NMDARs) are ligand-gated ion channels that play a critical role in synaptic plasticity, learning, and memory in the central nervous system (CNS). These receptors assemble into functionally diverse complexes composed of GluN1, GluN2, and GluN3 subunits. Among them, GluN1/GluN2A is expressed predominantly in adult brain, and its dysfunction has been implicated in various neuropathological conditions. Recent advances have identified several GluN2A-targeted agents, including highly selective negative allosteric modulators (NAMs). Structure-activity relationship (SAR) studies of existing agents have provided valuable insights into structural modifications that enhance pharmacological properties, offering promising avenues for therapeutic development.

Authors

Institutions

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2025-05-09
DOI
https://doi.org/10.1021/acsmedchemlett.5c00226
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advances in the Structural Basis of GluN2A-Selective Negative Allosteric Modulators

Steven H. Liang, Yinlong Li, Hongjie Yuan
ACS Medicinal Chemistry Letters
Neuroscience and Neuropharmacology Research
article

Advances in the Structural Basis of GluN2A-Selective Negative Allosteric Modulators

Steven H. Liang, Yinlong Li, Hongjie Yuan
article en

Abstract

<i>N</i>-Methyl-d-aspartate receptors (NMDARs) are ligand-gated ion channels that play a critical role in synaptic plasticity, learning, and memory in the central nervous system (CNS). These receptors assemble into functionally diverse complexes composed of GluN1, GluN2, and GluN3 subunits. Among them, GluN1/GluN2A is expressed predominantly in adult brain, and its dysfunction has been implicated in various neuropathological conditions. Recent advances have identified several GluN2A-targeted agents, including highly selective negative allosteric modulators (NAMs). Structure-activity relationship (SAR) studies of existing agents have provided valuable insights into structural modifications that enhance pharmacological properties, offering promising avenues for therapeutic development.

ACS Medicinal Chemistry LettersVol. 16(6)
Emory University (US)
National Institutes of Health
Openalex Percentile: Top 89%
Neuroscience and Neuropharmacology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Advances in the Structural Basis of GluN2A-Selective Negative Allosteric Modulators — Steven H. Liang, Yinlong Li, et al. · ACS Medicinal Chemistry Letters (2025) | TGRS Research Map | TGRS